Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas

A Correction to this article was published on 01 December 2001

Abstract

Carcinomas that develop in the pancreatic islets of transgenic mice expressing the SV40 T-antigens (Tag) under transcriptional control of the rat insulin II promoter (RIP) progress through well-characterized stages that are similar to aspects of human tumor progression, including hyperplastic growth, increased angiogenesis and reduced apoptosis1. The latter two stages have been associated with recurrent loss of heterozygosity (LOH)2 and reduced genome copy number3 on chromosomes 9 (LOH9) and 16 (LOH16), aberrations which we believe contribute to these phenotypes. Earlier analyses localized LOH9 to approximately 3 Mb and LOH16 to approximately 30 Mb (both syntenic with human 3q21–q25) but were limited by low throughput and a lack of informative polymorphic markers. Here we show that comparative genomic hybridization to DNA microarrays (array CGH)4,5,6,7 overcomes these limitations by allowing efficient, genome-wide analyses of relative genome copy number. The CGH arrays used in these experiments carried BACs distributed at 2–20-MB intervals across the mouse genome and at higher density in regions of interest. Using array CGH, we further narrowed the loci for LOH9 and LOH16 and defined new or previously unappreciated recurrent regions of copy-number decrease on chromosomes 6, 8 and 14 (syntenic with human chromosomes 12p11–p13, 16q24.3 and 13q11–q32, respectively) and regions of copy-number increase on chromosomes 2 and 4 (syntenic to human chromosomes 20q13.2 and 1p32–p36, respectively). Our analyses of human genome sequences syntenic to these regions suggest that CYP24, PFDN4, STMN1, CDKN1B, PPP2R3 and FSTL1 are candidate oncogenes or tumor-suppressor genes. We also show that irradiation and genetic background influence the spectrum of aberrations present in these tumors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: CGH analyses of genome copy number in murine tissues, tumors and cell lines.
Figure 2: Influence of normal genomic DNA contamination on detecting single copy-number abnormalities in tumors.
Figure 3: Frequency of occurrence of regions of aberration observed in 85 RIP-Tag tumors.
Figure 4: Identification of chromosome 16 interstitial deletions by array CGH delimits LOH16.
Figure 5: Genome Cryptographer annotation of human genomic sequence syntenic to the region of chromosome 9 loss encoding the apoptotic regulator PPP2R3.

Similar content being viewed by others

References

  1. Dietrich, W.F. et al. Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16. Proc. Natl Acad. Sci. USA 91, 9451–9455 (1994).

    Article  CAS  Google Scholar 

  2. Parangi, S., Dietrich, W., Christofori, G., Lander, E.S. & Hanahan, D. Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma. Cancer Res. 55, 6071–6076 (1995).

    CAS  PubMed  Google Scholar 

  3. Shi, Y.P. et al. DNA copy number changes associated with characteristic LOH in islet cell carcinomas of transgenic mice. Genes Chromosom. Cancer 19, 104–111 (1997).

    Article  CAS  Google Scholar 

  4. Pinkel, D. et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genet. 20, 207–211 (1998).

    Article  CAS  Google Scholar 

  5. Pollack, J.R. et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genet. 23, 41–46 (1999).

    Article  CAS  Google Scholar 

  6. Solinas-Toldo, S. et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20, 399–407 (1997).

    Article  CAS  Google Scholar 

  7. Heiskanen, M.A. et al. Detection of gene amplification by genomic hybridization to cDNA microarrays. Cancer Res. 60, 799–802 (2000).

    CAS  PubMed  Google Scholar 

  8. Telenius, H. et al. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 13, 718–725 (1992).

    Article  CAS  Google Scholar 

  9. Lander, E.S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001).

    Article  CAS  Google Scholar 

  10. Venter, J.C. et al. The sequence of the human genome. Science 291, 1304–1351 (2001).

    Article  CAS  Google Scholar 

  11. Collins, C. et al. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res. 11, 1034–1042 (2001).

    Article  CAS  Google Scholar 

  12. Albertson, D.G. et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genet. 25, 144–146 (2000).

    Article  CAS  Google Scholar 

  13. Vainberg, I.E. et al. Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin. Cell 93, 863–873 (1998).

    Article  CAS  Google Scholar 

  14. Iijima, M., Kano, Y., Nohno, T. & Namba, M. Cloning of cDNA with possible transcription factor activity at the G1-S phase transition in human fibroblast cell lines. Acta Med. Okayama 50, 73–77 (1996).

    CAS  PubMed  Google Scholar 

  15. Curmi, P.A. et al. Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br. J. Cancer 82, 142–150 (2000).

    Article  CAS  Google Scholar 

  16. Philipp-Staheli, J., Payne, S.R. & Kemp, C.J. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp. Cell Res. 264, 148–168 (2001).

    Article  CAS  Google Scholar 

  17. Fero, M.L., Randel, E., Gurley, K.E., Roberts, J.M. & Kemp, C.J. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396, 177–180 (1998).

    Article  CAS  Google Scholar 

  18. Deng, X., Ito, T., Carr, B., Mumby, M. & May, W.S. Jr. Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A. J. Biol. Chem. 273, 34157–34163 (1998).

    Article  CAS  Google Scholar 

  19. Chiang, C.W. et al. Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin-3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation. Blood 97, 1289–1297 (2001).

    Article  CAS  Google Scholar 

  20. Shibanuma, M., Mashimo, J., Mita, A., Kuroki, T. & Nose, K. Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-β 1–regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur. J. Biochem. 217, 13–19 (1993).

    Article  CAS  Google Scholar 

  21. Kupprion, C., Motamed, K. & Sage, E.H. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J. Biol. Chem. 273, 29635–29640 (1998).

    Article  CAS  Google Scholar 

  22. Efrat, S. et al. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc. Natl Acad. Sci. USA 85, 9037–9041 (1988).

    Article  CAS  Google Scholar 

  23. Han, C.S. et al. Construction of a BAC contig map of chromosome 16q by two-dimensional overgo hybridization. Genome Res. 10, 714–721 (2000).

    Article  CAS  Google Scholar 

  24. Shi, Y.P. et al. FISH probes for mouse chromosome identification. Genomics 45, 42–47 (1997).

    Article  CAS  Google Scholar 

  25. Korenberg, J.R. et al. Mouse molecular cytogenetic resource: 157 BACs link the chromosomal and genetic maps. Genome Res. 9, 514–523 (1999).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by USPHS grants CA78601 and R37-CA45234 and by the UCSF Comprehensive Cancer Center Core Grant (CA82103).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joe W. Gray.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hodgson, G., Hager, J., Volik, S. et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet 29, 459–464 (2001). https://doi.org/10.1038/ng771

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng771

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing